Cantitate/Preț
Produs

Fatty Acids and Oxidative Stress in Neuropsychiatric Disorders

Editat de Ravinder D., MD Reddy, Jeffrey K. Yao
en Limba Engleză Hardback – 19 feb 2007
Research into the role of oxidative stress and fatty acids in neuropsychiatric disorders has been ongoing for decades and has been written about before. However, this book aims to examine how these seemingly disparate bodies of evidence from the fields of oxidative stress and essential fatty acid metabolism are, in fact, intimately connected to each other. Therefore, for this book the editors invited researchers of oxidative stress (OS) and essential fatty acid (EFA) in neuropsychiatric disorders, exemplified by schizophrenia, mood disorders, Parkinson's disease and Alzheimer's disease. Together, the chapters bring a fresh perspective on the relationship between the presence of oxidative stress in the afore-mentioned disorders and the fatty acid deficits that have been identified in these disorders.
Citește tot Restrânge

Preț: 91722 lei

Preț vechi: 125098 lei
-27% Nou

Puncte Express: 1376

Preț estimativ în valută:
17559 18252$ 14559£

Carte disponibilă

Livrare economică 17-31 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781600216770
ISBN-10: 1600216773
Pagini: 288
Ilustrații: tables & colour photos
Dimensiuni: 187 x 262 x 25 mm
Greutate: 0.82 kg
Editura: Nova Science Publishers Inc

Cuprins

Preface; Fatty acids and Oxidative Stress: How are they connected?; Diet in Schizophrenia: An Overview; Oxidative Stress in Schizophrenia; Antipsychotic Agents and Oxidative Stress; Oxidative Stress in Parkinson's disease; Oxidative Stress and Altered Sphingolipid Metabolism in Alzheimer's Disease; Membrane Fatty Acid Deficits in Schizophrenia and Mood Disorders; Essential Fatty Acid Deficits in Neurodevelopmental Disorders; Fatty Acids and Oxidative Stress in Neurodevelopmental Disorders of Childhood: Treatment Implications; Essential Fatty Acid Supplementation in Schizophrenia and Mood Disorders; Bioactive Lipids, Niacin Sensitivity and Cognition in Schizophrenia; Schizophrenia, CAD and Omega-3 Fatty Acids;; Can Augmentation Enhance Antipsychotic Treatment Response in Schizophrenia? Omega-3 Fatty Acid and Antioxidant Supplementation; Apolipoprotein D and Arachidonic Acid Interactions in the Treatment and Pathology of Schizophrenia; Long-Chain Polyunsaturated Fatty Acids and Perinatal Origins of Schizophrenia; Unravelling Complexity by Integrative Biological Investigation.